General Information


DRACP ID  DRACP03650

Peptide Name  

Sequence  ILSLRWRWWKWKK

Sequence Length  13

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C95H140N26O15

Absent amino acids  ACDEFGHMNPQTVY

Common amino acids  W

Mass  210054

Pl  12.55

Basic residues  5

Acidic residues  0

Hydrophobic residues  7

Net charge  5

Boman Index  -2581

Hydrophobicity  -100

Aliphatic Index  90

Half Life 
  Mammalian: 20 hour
  Yeast: 30 min
  E.coli: >10 hour

Extinction Coefficient cystines  22000

Absorbance 280nm  1833.33

Polar residues  1

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 26902758

Title  Combined Bioinformatic and Rational Design Approach To Develop Antimicrobial Peptides against Mycobacterium tuberculosis

Doi Not available

Year  2016

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  9533

DRACP is developed by Dr.Zheng's team.